In addition, prevention of angiogenesis (neo-vascularization) due to downregulation of vascular endothelial growth factor (VEGF) has also been evidenced as chemotherapeutic mechanism of Cur against the BC [51, 52]. Here, VEGFA is linked to breast cancer.